Purple Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Purple Biotech and other ETFs, options, and stocks.About PPBT
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The oncology pipeline includes CM24, NT219, and CAPTN-3.
CEOGil Efron
CEOGil Efron
Employees9
Employees9
HeadquartersRehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded1968
Founded1968
Employees9
Employees9
PPBT Key Statistics
Market cap7.38M
Market cap7.38M
Price-Earnings ratio-0.74
Price-Earnings ratio-0.74
Dividend yield—
Dividend yield—
Average volume1.31M
Average volume1.31M
High today$0.8114
High today$0.8114
Low today$0.71
Low today$0.71
Open price$0.7955
Open price$0.7955
Volume531.27K
Volume531.27K
52 Week high$5.20
52 Week high$5.20
52 Week low$0.5326
52 Week low$0.5326
Stock Snapshot
The current Purple Biotech(PPBT) stock price is $0.74, with a market capitalization of 7.38M. The stock trades at a price-to-earnings (P/E) ratio of -0.74.
On 2025-12-13, Purple Biotech(PPBT) stock moved within a range of $0.71 to $0.81. With shares now at $0.74, the stock is trading +4.2% above its intraday low and -8.8% below the session's peak.
Trading activity shows a volume of 531.27K, compared to an average daily volume of 1.31M.
Over the past 52 weeks, Purple Biotech(PPBT) stock has traded between a high of $5.20 and a low of $0.53.
Over the past 52 weeks, Purple Biotech(PPBT) stock has traded between a high of $5.20 and a low of $0.53.